82 related articles for article (PubMed ID: 8392982)
1. L-myc proto-oncogene alleles and susceptibility to hepatocellular carcinoma.
Taylor JA; Bell DA; Nagorney D
Int J Cancer; 1993 Jul; 54(6):927-30. PubMed ID: 8392982
[TBL] [Abstract][Full Text] [Related]
2. Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer.
Isbir T; Yaylim I; Arikan S; Kaytan E; Karşidağ T; Bayrak S; Camlica H
Cancer Detect Prev; 2002; 26(6):454-7. PubMed ID: 12507230
[TBL] [Abstract][Full Text] [Related]
3. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
[TBL] [Abstract][Full Text] [Related]
4. EcoRI polymorphism of the L-myc gene in gastric cancer patients.
Dlugosz A; Adler G; Ciechanowicz A; Jaroszewicz-Heigelmann H; Starzynska T
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1231-5. PubMed ID: 12439118
[TBL] [Abstract][Full Text] [Related]
5. L-myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers.
Hsieh LL; Huang RC; Yu MW; Chen CJ; Liaw YF
Cancer Lett; 1996 Jun; 103(2):171-6. PubMed ID: 8635154
[TBL] [Abstract][Full Text] [Related]
6. Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases.
Shih CM; Kuo YY; Wang YC; Jian SL; Hsu YT; Wu HY; Guo MW; Wang YC
Lung Cancer; 2002 May; 36(2):125-32. PubMed ID: 11955646
[TBL] [Abstract][Full Text] [Related]
7. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
[TBL] [Abstract][Full Text] [Related]
9. Different susceptibility of each L-myc genotype to esophageal cancer risk factors.
Kumimoto H; Hamajima N; Nishizawa K; Nishimoto Y; Matsuo K; Harada H; Shinoda M; Hatooka S; Ishizaki K
Jpn J Cancer Res; 2001 Jul; 92(7):735-9. PubMed ID: 11473723
[TBL] [Abstract][Full Text] [Related]
10. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
ELBassuoni MA; Abd El Fatah G; Zaghla H
Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
[TBL] [Abstract][Full Text] [Related]
11. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
12. L-myc genotype is associated with different susceptibility to lung cancer in smokers.
Kumimoto H; Hamajima N; Nishimoto Y; Matsuo K; Shinoda M; Hatooka S; Ishizaki K
Jpn J Cancer Res; 2002 Jan; 93(1):1-5. PubMed ID: 11802801
[TBL] [Abstract][Full Text] [Related]
13. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients.
Hsu HC; Peng SY; Lai PL; Sheu JC; Chen DS; Lin LI; Slagle BL; Butel JS
Cancer; 1994 Jan; 73(1):42-7. PubMed ID: 7506118
[TBL] [Abstract][Full Text] [Related]
14. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
15. [L-myc and GSTM1 polymorphism in cerebral glioma].
Kondrat'eva TV; Imianitov EN; Togo AV; Zaĭtseva OA; Iatsuk OS; Bersnev VP; Khanson KP
Vopr Onkol; 1999; 45(5):523-7. PubMed ID: 10629710
[TBL] [Abstract][Full Text] [Related]
16. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma.
Rashad NM; El-Shal AS; Abd Elbary EH; Abo Warda MH; Hegazy O
Cytokine; 2014 Jul; 68(1):50-8. PubMed ID: 24656929
[TBL] [Abstract][Full Text] [Related]
17. c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis.
Abou-Elella A; Gramlich T; Fritsch C; Gansler T
Mod Pathol; 1996 Feb; 9(2):95-8. PubMed ID: 8657726
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men].
Liu S; Qiu XQ; Zeng XY; Bai H; Bei CH; Yang Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):463-7. PubMed ID: 23044206
[TBL] [Abstract][Full Text] [Related]
19. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
Zhang QX; Yao YQ; Li SL; Long Q
Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
[TBL] [Abstract][Full Text] [Related]
20. Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil.
Teixeira AC; Mendes CT; Marano LA; Deghaide NH; Secaf M; Elias J; Muglia V; Donadi EA; Martinelli AL
Hum Immunol; 2013 Aug; 74(8):1024-9. PubMed ID: 23632060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
